Diabetes Research and Clinical Practice
Volume 77, Issue 1 , Pages 107-112 , July 2007

Differences in coronary heart disease prevalence and risk factors in African and White patients with type 2 diabetes

  • W. John Kalk

      Affiliations

    • Corresponding Author InformationCorresponding author at: Diabetes Centre, Derbyshire Royal Infirmary, London Road, Derby DE1 2QY, United Kingdom. Tel.: +44 1332 347141x2710; fax: +44 1332 254836.
    • ,
  • Barry I. Joffe

Received 19 April 2006 ,Accepted 13 October 2006.

References 

  1. Diabetes Drafting Group . Prevalence of small and large vessel disease patients from 14 centres: the World Health Organisation multinational study on vascular disease in diabetics. Diabetologia. 1985;28:615–640
  2. Laasko M. Hyperglycaemia as a cardiovascular risk factor. Int. Diabetes Monit. 2000;12:1–5
  3. Laasko M, Ronnemaa T, Lehto S, Puukka P, Kallio V, Pyorala K. Does NIDDM increase the risk for coronary heart disease similarly in both low- and high-risk populations?. Diabetologia. 1995;38:487–493
  4. Bradshaw D, Dorrington R, Sitas F. The level of mortality in South Africa—what does it tell us about health?. S. Afr. Med. J. 1993;92:238–241
  5. Bhoola KD. A necropsy study of diabetes mellitus in Natal Blacks. S. Afr. Med. J. 1976;50:1364–1366
  6. Seftel HC, Raal FJ, Joffe BI. Dyslipidaemia in South Africa. In:  Fourie J,  Steyn K editor. Chronic Diseases of Life Style in South Africa. Parow, Cape: MRC Publications; 1995;
  7. Mollentze WF, Moore AJ, Steyn AF, Joubert G, Steyn K, Oosthuizen GM, et al. Coronary heart disease risk factors in a rural and urban Orange Free State Black population. S. Afr. Med. J. 1995;85:90–96
  8. Oelefse A, Jooste PL, Steyn K, Badenhorst CJ, Lombard C, Bourne L, et al. The lipid profile of the urban Black South African community of the Cape peninsula—the BRISK study. S. Afr. Med. J. 1996;86:162–166
  9. Steyn K, Fourie J, Lombard J, Katzenellenbogen J, Bourne J, Jooste P. Hypertension in the Black community of the Cape peninsula, South Africa. East Afr. Med. J. 1996;73:758–763
  10. Moodley J, Steyn K, Erlich RI, Jordaan E, Marais AD, Burgess L. Lipid and ischaemic heart disease risk factors in an urbanising South African workforce. S. Afr. Med. J. 1997;87:1615–1620
  11. Alberts M, Urdal P, Steyn K, Stensvold S, Tverdal A, Nel JH, et al. Prevalence of cardiovascular diseases and associated risk factors in a rural Black population of South Africa. Eur. J. Cardiovasc. Prev. Rehabil. 2005;12:247–354
  12. Joubert J, McLean CA, Reid CM, Pilloy W, Delport R, Steyn L, et al. Ischaemic heart disease in Black South African stroke patients. Stroke. 2000;31:1294–1298
  13. Levitt NS, Katzenellbogen JM, Bradshaw D, Hoffman MN, Bonnici F. The prevalence and risk factors for NIDDM in urban Africans in South Africa. Diabetes Care. 1993;16:601–607
  14. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N. Engl. J. Med. 2004;351:1296–1305
  15. Anavekar NS, McMurray JJV, Velazquez EJ, Solomon SD, Kober L, Rouleau J-L, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N. Engl. J. Med. 2004;351:1285–1295
  16. Freidewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of LDL-cholesterol in plasma without the use of the preparative centrifuge. Clin. Chem. 1972;18:499–502
  17. McLaughlin T, Abbasi F, Cheal K, Chu J, Lamendola C, Reaven G. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann. Intern. Med. 2003;139:802–809
  18. Wilson PWF, D’Agostino RB, Levy D, Belanger AM, Silberhatz H, Kanel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837–1847
  19. D’Angostino RB, Grundy S, Sullivan LM, Wilson P. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA. 2001;286:80–187
  20. Mbanya J-C, Sobngwi E. Diabetes microvascular and macrovascular disease in Africa. J. Cardivasc. Risk. 2003;10:191–193
  21. Morgan CL, Currie CJ, Stott NC, Smithers M, Butler CC, Peters JR. The prevalence of multiple diabetes-related complications. Diabet. Med. 2000;14:146–151
  22. Seflel HC, Walker ARP. Vascular disease in South African Bantu diabetics. Diabetologia. 1996;2:286–290
  23. Widen E, Ekstrand A, Saloranta C, Franssila-Kallunki A, Ericsson J, Schalin-Janti C, et al. Insulin resistance in type 2 (non-insulin dependent) diabetic patients with hypertriglycerideaemia. Diabetologia. 1992;35:1140–1145
  24. Lemieux I, Pascot A, Couillard C, Lamrche B, Tchernof A, Almeras N, et al. Hypertriglyceridemic waist A marker of the athero genie metabolic triad (hyperinsulinemia; hyperapolipoprotein B; dense LDL) in men?. Circulation. 2000;102:179–184
  25. Taniguchi A, Fukushima M, Sakai M, Miwa K, Makita T, Nagata I, et al. Remnant-like particle cholesterol, triglycerides, and insulin resistance in non-obese Japanese type 2 diabetic patients. Diabetes Care. 2000;23:1766–1769
  26. Shires R, Joffe BI, Seflel HC. Hormonal and metabolic responses to an oral glucose load in obese Black diabetics. S. Afr. Med. J. 1987;53:446–448
  27. Kalk WJ. Is insulinopenia in African NIDDM important?. Diabetologia. 1997;50:S112
  28. Stoney RM, O’Dea K, Herbert KE, Dragicevic G, Giles GG, Cumpston GN, et al. Insulin resistance as a major determinant of increased coronary heart disease inpostmenapausal women with type 2 diabetes mellitus. Diabetes Care. 2001;18:476–482
  29. Reaven G. Banting lecture 1988, role of insulin resistance in human disease. Diabetes. 1988;371:1095–1607
  30. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683–689
  31. Alexander CM, Landsman PB, Teutsch SM, Haffner SM. NCEP metabolic syndrome, diabetes mellitus and prevalence of coronary heart disease. Diabetes. 2003;52:1210–1214
  32. Bonora E, Targher G, Formentini G, Calcaterra F, Lombardi S, Marini F, et al. The metabolic syndrome is an independent predictor of cardiovascular disease in type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study. Diabet. Med. 2004;21:52–58
  33. Syvanne M, Taskinen MR. Lipids and lipoproteins as coronary risk factors in non-insulin dependent diabetes mellitus. Lancet. 1997;350:SI20–SI23
  34. Boizel R, Laporte F, Benhamou PY, Foulton T, Lardy B, Halimi S. Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels. Diabetes Care. 2000;23:1679–1685
  35. Leeder S, Gliksman M. Prospects for preventing heart disease. Br. Med. J. 1990;301:1004–1005
  36. Crook ED, Taylor H. Traditional and non-traditional risk factors for cardiovascular and renal disease in African Americans: a project of the Jackson Heart Study investigators. Am. J. Med. Sci. 2002;324:115
  37. Becker A, Kostense PJ, Bos G, Heine RJ, Bekker JM, Nijpels GN, et al. Hyperhomocysteinaemia is associated with coronary events in type 2 diabetes. J. Intern. Med. 2003;253:293–300
  38. US Renal Data System: USRDS 1999 Annual Data Report, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 1999.
  39. Young BA, Maynard C, Boyko EJ. Racial differences in diabetic nephropathy, cardiovascular disease and mortality in a national population of veterans. Diabetes Care. 2003;26:2392–2399
  40. Hostetter TH. Chronic kidney disease predicts cardiovascular disease. N. Engl. J. Med. 2004;351:1344–1346
  41. McEwan P, Williams JE, Griffiths JD, Bagust A, Peters JR, Hopkinson P, et al. Evaluating the performance of the Framingham risk equations in a population with diabetes. Diabet. Med. 2004;21:318–323
  42. Steyn K, Katzenellbergen JM, Lombard CJ, Bourne T. Urbanization and the risk for chronic diseases of lifestyle in the Black population of the Cape peninsula, South Africa. J. Cardiovasc. Risk. 1997;4:135–142
  43. Asia Pacific Cohort Studies Collaboration. A comparison of the associations between risk factors and cardiovascular disease in Asia and Australasia. Eur. J. Cardiovasc. Prev. Rehabil. 2005;12:484–491
  44. Sumner AE, Fiiley KB, Genovese DJ, Criqui MH, Boston RC. Fasting triglycerides and the triglyceride-HDL chlesterol ratio are not markers of insulin resistance in African Americans. Arch. Intern. Med. 2005;165:1400–1595
  45. Kalk WJ, Joffe BI. Low prevalence of the metabolic syndrome in diabetic African men by ATP III and IDF definitions: a study in African, White and south Asian men and women. In: Abstract volume, EASD 42nd Annual Meeting. 2006;p. 236
  46. van der Merwe M-T, Panz VR, Crowther NJ, Schhphoff GP, Gray IP, Froguel P, et al. Intern. J. Obes. 1999;23:909–917
  47. Joffe BI, Distiller DA, Kalk WJ. Lipid levels in Black South Africans with Type 2 diabetes. Diabetes Care. 2004;27:1829–1840
  48. Cooper RS, Ghali JK. Coronary heart disease: Black-White differences in coronary heart disease in diabetic African-American women. Cardiovasc. Clin. 1991;21:205–225

☆ Presented in part at the XV International Symposium on Drugs Affecting Lipid Metabolism, Venice, 2004.

PII: S0168-8227(06)00485-2

doi: 10.1016/j.diabres.2006.10.014

Diabetes Research and Clinical Practice
Volume 77, Issue 1 , Pages 107-112 , July 2007

Article Tools